First-in-human study of 23ME-00610, an antagonistic antibody for genetically validated CD200R1 immune checkpoint, in participants with advanced solid malignancies.

23ME-00610 - 23andMe

http://www.ncbi.nlm.nih.gov/pubmed/39651931

Albiruni Abdul Razak; Anh N Diep; Chris German; Clifford Hom; Drew Rasco; Dylan M Glatt; Maike Schmidt; Sariah Kell; Scott Laurie; Shivaani Kummar; Sophia R Majeed; Suyash S Shringarpure

Dec 10, 2024